Alnylam Wins FDA OK for First Therapy for Rare Blood Disorder

November 25, 2019

The first treatment for adult patients who suffer from a rare inherited blood disorder that increases the production of toxic molecules passed Food and Drug Administration (FDA), the agency said November 20.

Related Stories